Articles by Control, a senior compliance officer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Control, a senior compliance officer

Holding Back

If not properly monitored, filters and plastic bags can keep back more than they should.
Mar 2, 2008

If not properly monitored, filters and plastic bags can keep back more than they should.

AIM-less

If at first the product fails, then inspect, inspect again
Feb 2, 2008

If at first the product fails, then inspect, inspect again

Trash and Treasures

Process efficiency is measured not only by what is kept, but also by what is thrown away.
Jan 2, 2008

Process efficiency is measured not only by what is kept, but also by what is thrown away.

Why We Do What We Do

The "why" things are done in this industry is just as important as the "what"and "how."
Dec 2, 2007

The "why" things are done in this industry is just as important as the "what"and "how."

Agent in Place: Statistically Unstable

Thin are the lines that separate stability, statistics, and chaos.
Nov 2, 2007

Thin are the lines that separate stability, statistics, and chaos.

Agent in Place: Vials and Villains

Our files pull up lost contracts, poor competitive tactics, and an over-ambitious employee.
Oct 2, 2007

Our files pull up lost contracts, poor competitive tactics, and an over-ambitious employee.

Self-destruction

Poor processing and misguided projections lead to trashed product.
Sep 2, 2007

Poor processing and misguided projections lead to trashed product.

Supplier Woes

Production sometimes follows the law of supply and reprimand.
Aug 2, 2007

Production sometimes follows the law of supply and reprimand.

What Once Was

The good ol' days weren't always good.
Jul 2, 2007

The good ol' days weren't always good.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here